114 related articles for article (PubMed ID: 30177483)
1. The CKD plasma lipidome varies with disease severity and outcome.
Duranton F; Laget J; Gayrard N; Saulnier-Blache JS; Lundin U; Schanstra JP; Mischak H; Weinberger KM; Servel MF; Argilés A
J Clin Lipidol; 2019; 13(1):176-185.e8. PubMed ID: 30177483
[TBL] [Abstract][Full Text] [Related]
2. Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy.
Michalczyk A; Dołęgowska B; Heryć R; Chlubek D; Safranow K
Lipids Health Dis; 2019 Apr; 18(1):85. PubMed ID: 30947711
[TBL] [Abstract][Full Text] [Related]
3. High-Density Lipoprotein Lipidomics and Mortality in CKD.
Lidgard B; Hoofnagle AN; Zelnick LR; de Boer IH; Fretts AM; Kestenbaum BR; Lemaitre RN; Robinson-Cohen C; Bansal N
Kidney Med; 2023 Oct; 5(10):100708. PubMed ID: 37731962
[TBL] [Abstract][Full Text] [Related]
4. Plasma Lipidomics Investigation of Hemodialysis Effects by Using Liquid Chromatography-Mass Spectrometry.
Wang L; Hu C; Liu S; Chang M; Gao P; Wang L; Pan Z; Xu G
J Proteome Res; 2016 Jun; 15(6):1986-94. PubMed ID: 27151145
[TBL] [Abstract][Full Text] [Related]
5. Vitamin B6 metabolism in chronic kidney disease--relation to transsulfuration, advanced glycation and cardiovascular disease.
Busch M; Göbert A; Franke S; Ott U; Gerth J; Müller A; Stein G; Bitsch R; Wolf G
Nephron Clin Pract; 2010; 114(1):c38-46. PubMed ID: 19816042
[TBL] [Abstract][Full Text] [Related]
6. Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism.
Chen H; Chen L; Liu D; Chen DQ; Vaziri ND; Yu XY; Zhang L; Su W; Bai X; Zhao YY
J Proteome Res; 2017 Apr; 16(4):1566-1578. PubMed ID: 28286957
[TBL] [Abstract][Full Text] [Related]
7. Serum lipid profile and plasma fatty acid composition in hemodialysis patients--comparison with chronic kidney disease patients.
Nakamura N; Fujita T; Kumasaka R; Murakami R; Shimada M; Shimaya Y; Osawa H; Yamabe H; Okumura K
In Vivo; 2008; 22(5):609-11. PubMed ID: 18853755
[TBL] [Abstract][Full Text] [Related]
8. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry-Based Lipidomics Reveals Differential Changes in the Accumulated Lipid Classes in Chronic Kidney Disease.
Marczak L; Idkowiak J; Tracz J; Stobiecki M; Perek B; Kostka-Jeziorny K; Tykarski A; Wanic-Kossowska M; Borowski M; Osuch M; Formanowicz D; Luczak M
Metabolites; 2021 Apr; 11(5):. PubMed ID: 33925471
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels.
Abujrad H; Mayne J; Ruzicka M; Cousins M; Raymond A; Cheesman J; Taljaard M; Sorisky A; Burns K; Ooi TC
Atherosclerosis; 2014 Mar; 233(1):123-9. PubMed ID: 24529132
[TBL] [Abstract][Full Text] [Related]
11. Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study.
Garoufi A; Drapanioti S; Marmarinos A; Askiti V; Mitsioni AJ; Mila M; Grigoriadou G; Georgakopoulos D; Stefanidis CJ; Gourgiotis D
BMC Nephrol; 2017 Mar; 18(1):113. PubMed ID: 28359257
[TBL] [Abstract][Full Text] [Related]
12. Intestinal fatty acid-binding protein levels in patients with chronic renal failure.
Okada K; Sekino M; Funaoka H; Sato S; Ichinomiya T; Murata H; Maekawa T; Nishikido M; Eishi K; Hara T
J Surg Res; 2018 Oct; 230():94-100. PubMed ID: 30100046
[TBL] [Abstract][Full Text] [Related]
13. Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism.
Czumaj A; Śledziński T; Carrero JJ; Stepnowski P; Sikorska-Wisniewska M; Chmielewski M; Mika A
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109090
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Fatty Acid Profiles in a Group of Female Patients with Chronic Kidney Diseases (CKD) and Metabolic Syndrome (MetS)⁻Similar Trends of Changes, Different Pathophysiology.
Szczuko M; Kaczkan M; Drozd A; Maciejewska D; Palma J; Owczarzak A; Marczuk N; Rutkowski P; Małgorzewicz S
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959940
[TBL] [Abstract][Full Text] [Related]
15. The significance of plasma lysophospholipids in patients with renal failure on hemodialysis.
Sasagawa T; Suzuki K; Shiota T; Kondo T; Okita M
J Nutr Sci Vitaminol (Tokyo); 1998 Dec; 44(6):809-18. PubMed ID: 10197312
[TBL] [Abstract][Full Text] [Related]
16. Protein oxidation in chronic kidney disease.
Caimi G; Carollo C; Hopps E; Montana M; Lo Presti R
Clin Hemorheol Microcirc; 2013; 54(4):409-13. PubMed ID: 23719419
[TBL] [Abstract][Full Text] [Related]
17. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
18. Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease.
Baek J; He C; Afshinnia F; Michailidis G; Pennathur S
Nat Rev Nephrol; 2022 Jan; 18(1):38-55. PubMed ID: 34616096
[TBL] [Abstract][Full Text] [Related]
19. Abdominal aorta and pelvic artery calcifications on plain radiographs may predict mortality in chronic kidney disease, hemodialysis and renal transplantation.
Disthabanchong S; Vipattawat K; Phakdeekitcharoen B; Kitiyakara C; Sumethkul V
Int Urol Nephrol; 2018 Feb; 50(2):355-364. PubMed ID: 29236239
[TBL] [Abstract][Full Text] [Related]
20. Impaired
Afshinnia F; Rajendiran TM; Soni T; Byun J; Wernisch S; Sas KM; Hawkins J; Bellovich K; Gipson D; Michailidis G; Pennathur S;
J Am Soc Nephrol; 2018 Jan; 29(1):295-306. PubMed ID: 29021384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
